Colleen Kuchta
About Colleen Kuchta
Colleen Kuchta is the Director of Pharmacovigilance Quality and Compliance at Bristol Myers Squibb, with extensive experience in patient safety and regulatory compliance in the pharmaceutical industry.
Company
Colleen Kuchta is currently employed at Bristol Myers Squibb as the Director of Pharmacovigilance Quality and Compliance. Her role is conducted remotely in the United States. Bristol Myers Squibb is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines for patients with serious diseases.
Title
Colleen Kuchta holds the title of Director, Pharmacovigilance Quality and Compliance at Bristol Myers Squibb. Her role involves overseeing the quality and compliance aspects of pharmacovigilance activities to ensure patient safety and regulatory adherence.
Education and Expertise
Colleen Kuchta has a comprehensive educational background in biology and business administration. She earned a Bachelor of Science in Biology from West Chester University of Pennsylvania from 1997 to 2001. She later pursued a Master’s in Business Administration at Wilmington University from 2009 to 2010. Additionally, she holds certificates in Lean Six Sigma from Villanova University, acquired between 2014 and 2015. Her expertise includes managing safety data exchange agreements, vendor relationships, inspections, audits, and clinical trials.
Professional Background
Colleen Kuchta has an extensive career in the pharmaceutical industry. She began her career as a Biologist at Wyeth Pharmaceuticals from 2001 to 2003. She then joined AstraZeneca in 2003, where she held various roles such as Study Delivery Associate, Study Delivery Operations Specialist, and Patient Safety Principle. She was later promoted to Associate Director and then to Director in Patient Safety Compliance. From 2021 to 2024, she worked at Mirati Therapeutics as Director, Pharmacovigilance Quality and Compliance. In 2024, she transitioned to Bristol Myers Squibb.
Achievements
Throughout her career, Colleen Kuchta has been recognized for her leadership and excellence. While at AstraZeneca, she received multiple awards for her contributions. At Mirati Therapeutics, she played a crucial role in developing and implementing a robust pharmacovigilance (PV) quality management system. Her work focuses on ensuring patient safety, regulatory compliance, and continuous improvement.